Target intelligence / Profile preview

Charged multivesicular body protein 4B (CHMP4B)

Target
CHMP4B
Molecular classification
ESCRT-III complex component, Membrane-associated scaffolding protein, Other (not a receptor, enzyme, transporter, or ion channel)
01

Overview

Charged multivesicular body protein 4B (CHMP4B) is a core component of the ESCRT-III complex, which plays a critical role in sorting endocytosed surface receptors into multivesicular endosomes for degradation, as well as in the scission of membrane necks during cytokinesis and the budding of enveloped viruses such as HIV-1. CHMP4B assembles into membrane-attached spiral or filamentous scaffolds that drive or stabilize membrane deformation and budding processes. Interaction with proteins such as ALIX (PDCD6IP) is essential for its function in the ESCRT pathway. Mutations in CHMP4B disrupt vesicular trafficking and are associated with autosomal dominant cataracts. Although this protein is biologically important, it is not currently the target of clinically approved drugs, but it has relevance in research on cell division, viral replication, and hereditary disease.

Other names
SNF7-2VPS32BVps32-2SHAX1C20orf178CHMP4bhSnf7-2dJ553F4.4Shax1Chromatin-modifying protein 4bVacuolar protein sorting-associated protein 32-2SNF7 homolog associated with Alix 1CTPP3CTRCT31CHMP4A
02

Mechanism of action

Not applicable: no drugs directly targeting CHMP4B are approved. For research compounds: hypothesized disruption of ESCRT-III polymerization or inhibition of protein-protein interactions needed for vesicle scission and viral budding.

03

Biological functions

Endosomal sorting and multivesicular body (MVB) formationMembrane remodeling and scissionCytokinesis (final stage of cell division)Exosomal release of cellular components (e.g., SDCBP, CD63, syndecan)Viral budding (especially enveloped viruses like HIV-1)Structural support for primary cilia formation (via association with F-actin)
04

Disease associations

Autosomal dominant posterior polar cataractsEarly-onset posterior polar cataractsCancer (indirectly related through ESCRT function in cell division and viral budding)Infection (HIV release, other enveloped virus replication cycles)
05

Safety considerations

Therapeutically targeting ESCRT-III proteins like CHMP4B may pose risks for basic cell division, endosomal processing, and vesicle trafficking, which are fundamental processes in most cell types. This could lead to unintended toxicity, especially in proliferative tissues.Surgical or gene therapy targeting for cataract is established, but not for direct protein inhibition.
06

Biomarkers

Mutations in CHMP4B (e.g., for hereditary cataracts and possibly in context of cell proliferation or ESCRT dysfunction)

Beyond the preview

Go deeper on Charged multivesicular body protein 4B (CHMP4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Charged multivesicular body protein 4B (CHMP4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call